background
novel
coronaviru
sever
acut
respiratori
syndrom
corona
viru
method
confirm
patient
divid
cvd
noncvd
group
accord
medic
histori
medic
record
inform
includ
demograph
data
medic
histori
clinic
characterist
laboratori
examin
chest
comput
tomographi
ct
well
treatment
measur
collect
analyz
compar
two
group
result
patient
cvd
show
sever
patholog
chang
lung
elev
injuryrel
enzym
includ
dehydrogenas
hdbh
lactat
dehydrogenas
ldh
ggt
creatin
kinas
ck
alanin
aminotransferas
alt
significantli
increas
uncontrol
inflamm
relat
marker
creactiv
protein
crp
interleukin
il
serum
ferritin
erythrocyt
sediment
rate
esr
serum
amyloid
saa
seriou
hypercoagul
statu
reflect
increas
ddimer
serum
fibrinogen
fib
higher
mortal
compar
patient
without
cvd
conclus
data
indic
cvd
strong
risk
factor
rapid
progress
bad
prognosi
intens
medic
care
appli
patient
cvd
prevent
rapid
deterior
diseas
patient
cvd
experienc
sever
pneumonia
patient
cvd
show
tissu
injuryrel
enzym
releas
patient
cvd
higher
risk
cytokin
storm
patient
cvd
higher
risk
hypercoagul
state
cvd
risk
factor
progress
prognosi
corona
viru
diseas
covid
first
report
decemb
wuhan
china
novel
betecoronaviru
initi
design
renam
global
consensu
mar
diseas
spread
countri
includ
usa
itali
iran
etc
confirm
patient
death
patient
mildli
ill
flulik
symptom
fever
cough
etc
howev
also
mani
patient
develop
acut
respiratori
distress
syndrom
ard
multipl
organ
failur
mof
short
time
mortal
critic
patient
report
high
previou
studi
found
patient
comorbid
infect
sarscov
merscov
like
progress
ard
even
death
dramat
increas
patient
infect
clinician
pay
attent
impact
underli
diseas
prognosi
descript
studi
case
show
patient
coexist
disord
among
hypertens
diabet
coronari
heart
diseas
top
three
underli
diseas
yang
x
et
al
report
older
patient
year
comorbid
ard
increas
risk
death
therefor
comorbid
confirm
correl
sever
could
lead
poor
prognosi
death
cvd
lead
global
caus
death
account
million
death
number
might
reach
million
sever
investig
demonstr
higher
suscept
merscov
human
papillomaviru
infect
cvd
patient
probabl
owe
endotheli
dysfunct
metabol
abnorm
increas
proinflammatori
cytokin
eventu
lead
impair
immun
function
addit
cvd
risk
factor
poor
prognosi
significantli
increas
mortal
mer
sever
clinic
studi
shown
cvd
common
comorbid
patient
proport
patient
cvd
higher
critic
ill
dead
case
figur
whether
cvd
potenti
risk
factor
extent
dose
influenc
progress
prognosi
patient
includ
cvd
without
cvd
admit
wuhan
union
hospit
februari
februari
includ
studi
accord
inclus
criteria
basic
inform
laboratori
examin
chest
ct
scan
treatment
collect
analyz
found
cvd
associ
progress
poor
prognosi
retrospect
studi
data
analysi
perform
anonym
studi
approv
institut
ethic
board
wuhan
union
hospit
tongji
medic
colleg
huazhong
univers
scienc
technolog
requir
inform
consent
waiv
ethic
commiss
design
hospit
emerg
infecti
diseas
admit
patient
wuhan
union
hospit
februari
screen
confirm
patient
order
avoid
interfer
diseas
prognosi
patient
underli
diseas
exclud
studi
end
patient
cvd
without
cvd
enrol
studi
addit
ct
imag
score
use
quantifi
patholog
chang
lung
patient
lobe
lobe
total
assign
score
describ
previous
total
ct
score
everi
patient
consensu
two
physician
blind
clinic
inform
patient
data
analysi
perform
among
patient
cvd
patient
without
cvd
categor
variabl
summar
count
percentag
continu
variabl
express
median
interquartil
rang
iqr
simpl
rang
appropri
imput
made
miss
data
categor
variabl
compar
use
test
fisher
exact
test
use
data
limit
continu
variabl
compar
use
independ
group
test
data
normal
distribut
otherwis
mannwhitney
test
use
risk
factor
analysi
base
logist
regress
analysi
data
statist
appli
use
spss
softwar
p
regard
signific
differ
demograph
clinic
characterist
patient
shown
tabl
median
age
patient
year
iqr
patient
male
patient
two
common
cvd
hypertens
coronari
heart
diseas
top
five
symptom
fever
short
breath
poor
appetit
cough
sputum
product
wherea
myalgia
chill
pharyngalgia
headach
rel
rare
compar
patient
without
cvd
patient
cvd
older
poorer
appetit
nausea
vomit
well
sever
case
mortal
howev
signific
differ
gender
baselin
symptom
time
onset
symptom
hospit
admiss
two
group
cvd
group
older
order
assess
impact
age
progress
perform
logist
regress
analysi
result
show
cvd
risk
factor
sever
event
age
studi
tabl
ct
scan
perform
time
admiss
common
characterist
chest
ct
groundglass
opac
bilater
patchi
shadow
figur
moreov
patient
cvd
promin
radiolog
abnorm
without
cvd
furthermor
sever
patholog
chang
evalu
quantifi
score
system
describ
found
patient
cvd
present
higher
ct
imag
score
compar
patient
without
cvd
figur
patient
abnorm
laboratori
test
result
tabl
worthi
note
level
enzym
dehydrogenas
hbdh
alanin
aminotransferas
alt
lactic
dehydrogenas
ldh
ggt
alkalin
phosphatas
alp
creatin
kinas
ck
higher
patient
cvd
tabl
figur
furthermor
level
neutrophil
saa
crp
serum
ferritin
esr
well
ddimer
fib
also
significantli
higher
patient
cvd
tabl
figur
beyond
level
total
protein
tp
prealbumin
albumin
alb
tabl
figur
well
absolut
count
lymphocyt
red
blood
cell
rbc
level
hemoglobin
tabl
figur
significantli
lower
cvd
group
compar
noncvd
group
data
show
patient
cvd
higher
risk
tissu
injuryrel
enzym
releas
excess
uncontrol
inflamm
respons
hypercoagul
state
may
contribut
poorer
prognosi
prognosi
patient
regul
mani
factor
patient
underli
diseas
tumor
cvd
like
advers
outcom
howev
patholog
featur
patient
cvd
well
understood
order
address
role
cvd
progress
prognosi
clinic
characterist
patient
identifi
provid
foundat
risk
factor
manag
therefor
studi
retrospect
analyz
differ
basic
characterist
laboratori
test
patient
without
cvd
tri
explain
differ
previou
studi
suggest
age
gender
obes
risk
factor
cvd
well
poor
prognosi
studi
find
patient
cvd
show
older
median
age
higher
bmi
score
compar
without
cvd
age
risk
factor
sever
condit
differ
gender
composit
addit
common
symptom
found
gastrointestin
symptom
includ
poor
appetit
nausea
vomit
like
occur
patient
cvd
may
relat
drug
patient
use
patient
cvd
control
blood
pressur
use
aceiarb
drug
inhibit
activ
ace
howev
despit
similar
structur
ace
acei
drug
inhibit
activ
ferrario
et
al
found
express
rat
increas
administr
acei
arb
drug
respect
enter
cell
bind
receptor
surfac
highli
express
mucos
epitheli
cell
respiratori
digest
tract
therefor
patient
cvd
use
aceiarb
drug
control
blood
pressur
may
vulner
viru
invad
digest
symptom
infect
furthermor
use
acei
drug
patient
viral
pneumonia
reduc
incid
advers
outcom
suggest
use
patient
chest
ct
imag
use
refer
diseas
sever
assess
next
analyz
chang
chest
ct
imag
cvd
noncvd
group
predict
ct
imag
score
patient
cvd
higher
without
cvd
mean
cvd
patient
sever
inde
mortal
patient
cvd
group
significantli
higher
noncvd
group
advers
outcom
patient
associ
damag
multipl
organ
reflect
elev
enzym
although
result
show
enzym
level
normal
rang
level
enzym
cvd
group
significantli
higher
noncvd
group
mean
patient
cvd
like
suffer
multipl
organ
dysfunct
syndrom
mod
addit
research
found
could
bind
myocardi
cell
lead
signific
increas
myocardi
injuri
marker
howev
due
patholog
chang
myocardi
cell
patient
cvd
suscept
damag
may
reason
differ
multipl
enzym
releas
two
group
patient
furthermor
level
total
protein
albumin
prealbumin
red
blood
cell
hemoglobin
patient
cvd
significantli
lower
compar
without
cvd
indic
potenti
immun
dysfunct
data
display
lower
lymphocyt
count
higher
proinflammatori
cytokin
level
cvd
group
signifi
increas
occurr
cytokin
storm
patient
accord
previou
research
cytokin
storm
play
import
role
pathogenesi
sar
mer
also
import
caus
death
addit
cytokin
storm
link
damag
myocardi
cell
may
relat
cardiovascular
complic
patient
sarscov
infect
ssa
increas
patient
associ
sever
diseas
level
indic
patient
cvd
significantli
higher
without
cvd
result
indic
patient
cvd
like
form
inflammatori
storm
eventu
lead
rapid
deterior
patient
process
infect
pulmonari
inflamm
prevent
oxygen
exchang
alveolar
lead
hypoxia
bodi
activ
fibrinolyt
system
compar
noncvd
group
level
ddimer
fib
higher
patient
cvd
group
mean
prone
hypercoagul
worth
note
hypercoagul
state
like
caus
cardiovascular
event
acut
myocardi
infarct
ami
two
patient
suffer
ami
hospit
cvd
group
data
shown
hypercoagul
state
also
increas
risk
pulmonari
embol
explain
sudden
occurr
complic
hypoxia
heart
failur
studi
six
death
case
occur
cvd
group
caus
respiratori
failur
circulatori
failur
consist
predict
laboratori
test
sum
data
indic
patient
cvd
show
sever
clinic
symptom
lung
injuri
tissu
injuryrel
enzym
releas
excess
uncontrol
cytokin
storm
hypercoagul
state
compar
noncvd
patient
therefor
cvd
regard
risk
factor
progress
prognosi
cvd
make
difficult
treatment
pay
attent
cvd
patient
prevent
rapid
deterior
diseas
author
conflict
interest
note
repres
ct
imag
patient
cvd
patient
without
cvd
b
ct
score
patient
cvd
patient
without
cvd
p
consid
statist
signific
